This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Oct 10;25(29):4689-90; author reply 4690-1.

doi: 10.1200/JCO.2007.12.6888.

Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without evidence

PMID: 17925567
DOI: 10.1200/JCO.2007.12.6888

Comment

Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without evidence

Kurt Hellmann. J Clin Oncol. 2007.

. 2007 Oct 10;25(29):4689-90; author reply 4690-1.

doi: 10.1200/JCO.2007.12.6888.

Author

PMID: 17925567
DOI: 10.1200/JCO.2007.12.6888

No abstract available

PubMed Disclaimer

Comment on

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL. Tebbi CK, et al. J Clin Oncol. 2007 Feb 10;25(5):493-500. doi: 10.1200/JCO.2005.02.3879. J Clin Oncol. 2007. PMID: 17290056 Clinical Trial.

Similar articles

Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence.
Lipshultz SE, Lipsitz SR, Orav EJ. Lipshultz SE, et al. J Clin Oncol. 2007 Jul 20;25(21):3179; author reply 3180. doi: 10.1200/JCO.2007.11.8778. J Clin Oncol. 2007. PMID: 17634500 No abstract available.
Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL. Tebbi CK, et al. J Clin Oncol. 2007 Feb 10;25(5):493-500. doi: 10.1200/JCO.2005.02.3879. J Clin Oncol. 2007. PMID: 17290056 Clinical Trial.
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.
Barry EV, Vrooman LM, Dahlberg SE, Neuberg DS, Asselin BL, Athale UH, Clavell LA, Larsen EC, Moghrabi A, Samson Y, Schorin MA, Cohen HJ, Lipshultz SE, Sallan SE, Silverman LB. Barry EV, et al. J Clin Oncol. 2008 Mar 1;26(7):1106-11. doi: 10.1200/JCO.2007.12.2481. J Clin Oncol. 2008. PMID: 18309945 Clinical Trial.
Emerging drugs for Hodgkin's lymphoma.
Böll B, Borchmann P, Diehl V. Böll B, et al. Expert Opin Emerg Drugs. 2010 Dec;15(4):585-95. doi: 10.1517/14728214.2010.505602. Epub 2010 Jul 15. Expert Opin Emerg Drugs. 2010. PMID: 20629601 Review.
Carcinogenic effects of chemotherapeutic compounds.
Klein-Szanto AJ. Klein-Szanto AJ. Prog Clin Biol Res. 1992;374:167-74. Prog Clin Biol Res. 1992. PMID: 1620702 Review. No abstract available.

See all similar articles

Cited by

Cardiovascular effects in childhood cancer survivors treated with anthracyclines.
Franco VI, Henkel JM, Miller TL, Lipshultz SE. Franco VI, et al. Cardiol Res Pract. 2011 Feb 10;2011:134679. doi: 10.4061/2011/134679. Cardiol Res Pract. 2011. PMID: 21331374 Free PMC article.
Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.
Zhang J, Cui X, Yan Y, Li M, Yang Y, Wang J, Zhang J. Zhang J, et al. Am J Transl Res. 2016 Jul 15;8(7):2862-75. eCollection 2016. Am J Transl Res. 2016. PMID: 27508008 Free PMC article. Review.
Cardiovascular disease in adult survivors of childhood cancer.
Lipshultz SE, Franco VI, Miller TL, Colan SD, Sallan SE. Lipshultz SE, et al. Annu Rev Med. 2015;66:161-76. doi: 10.1146/annurev-med-070213-054849. Annu Rev Med. 2015. PMID: 25587648 Free PMC article. Review.
Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group.
Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, de Alarcón PA, Schwartz C, Chauvenet A. Tebbi CK, et al. Pediatr Blood Cancer. 2012 Dec 15;59(7):1259-65. doi: 10.1002/pbc.24279. Epub 2012 Aug 21. Pediatr Blood Cancer. 2012. PMID: 22911615 Free PMC article. Clinical Trial.
Strategies to prevent anthracycline-related congestive heart failure in survivors of childhood cancer.
Armenian SH, Gelehrter SK, Chow EJ. Armenian SH, et al. Cardiol Res Pract. 2012;2012:713294. doi: 10.1155/2012/713294. Epub 2012 Aug 15. Cardiol Res Pract. 2012. PMID: 22928146 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information